DNCLI1 Antibodies

Santa Cruz Biotechnology provides a broad selection of DNCLI1 monoclonal antibodies for advanced research in cellular biology. DNCLI1 monoclonal antibodies perform effectively in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DNCLI1, or Dendritic Cell Neuron-Related Protein 1, plays a crucial role in the regulation of neuronal and immune cell interactions, influencing both neuroinflammatory responses and neuronal development. Understanding DNCLI1 function is essential for elucidating its involvement in neurodegenerative diseases and immune system disorders. The study of DNCLI1 continues to reveal new insights into cellular mechanisms and potential therapeutic targets. Researchers worldwide are actively investigating DNCLI1's role in various neurological conditions and immune responses. Current research focuses on understanding how DNCLI1 influences cellular signaling pathways and protein interactions. DNCLI1 investigations have opened new avenues for understanding disease progression and potential treatments. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies for neurological and immune disorders.